University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

The nods allow Regeneron to better compete with Roche, which stormed the market in 2022 with Vabysmo. The Swiss drugmaker's ...

We’re excited to present a review of our robust data package at OIS, highlighting our momentum toward advancing this innovation into clinical evaluation.” About VLTR-559 VLTR-559 is a long-acting anti ...